# Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)

> **NCT00686686** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 23 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **BIOLOGICAL:** Infliximab

## Key facts

- **NCT ID:** NCT00686686
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-02
- **Final completion:** 2009-04
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686686, "Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00686686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*